Northwestern Mutual Wealth Management
TCRT icon

Northwestern Mutual Wealth Management’s Alaunos Therapeutics TCRT Stock Holding History

Northwestern Mutual Wealth Management’s Portfolio TCRT Stock Details TCRT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-17
Closed -$116 – 3843
2024
Q2 		$116 Buy
+17
New +$203 ﹤0.01% 3385
2022
Q1 		– Sell
-4
Closed -$1K – 3388
2021
Q4 		$1K Buy
+4
New +$879 ﹤0.01% 3064
2018
Q2 		– Sell
-7
Closed -$4K – 2486
2018
Q1 		$4K Buy
+7
New +$4.36K ﹤0.01% 1951
2016
Q2 		– Sell
-3
Closed -$4K – 2254
2016
Q1 		$4K Buy
+3
New +$3.07K ﹤0.01% 1735

Other funds holding TCRT

MP
MSD Partners New York $82.3M AUM 15.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
Group One Trading
Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return
SWM
Sugarloaf Wealth Management Duluth, Georgia $529M AUM 14.14% 1-Year Est. Return

Northwestern Mutual Wealth Management's TCRT Position: Q3 2024 in Review

Northwestern Mutual Wealth Management sold out of Alaunos Therapeutics (TCRT) in Q3 2024, closing a stake of 17 shares — an estimated $116 sold.

Northwestern Mutual Wealth Management first reported a position in TCRT in Q1 2016 and held it in 4 quarters. The position peaked at $4K in Q1 2018. 29 funds tracked by Wall St. Rank hold TCRT as of Q3 2024.

  • Northwestern Mutual Wealth Management reported no remaining Alaunos Therapeutics position as of Q3 2024 after selling out during the quarter.
  • Northwestern Mutual Wealth Management sold 17 Alaunos Therapeutics shares in Q3 2024, an estimated $116.
  • Northwestern Mutual Wealth Management first reported a position in Alaunos Therapeutics in Q1 2016 and held it in 4 quarters.
  • Northwestern Mutual Wealth Management's Alaunos Therapeutics position peaked at $4K in Q1 2018.
  • 29 funds tracked by Wall St. Rank held Alaunos Therapeutics as of Q3 2024.

Based on Northwestern Mutual Wealth Management's 13F filing for Q3 2024, filed 12 Nov 2024.